The herpes simplex virus type 1 (HSV-1) a protein ICP27 regulates the transition between the delayed-early and late phases of the viral infection. Previous genetic analyses have suggested that the important functional domains of ICP27 map to its carboxyl-terminal half. One striking feature of the primary sequence of ICP27, however, is an extremely acidic region near its amino terminus. To determine whether this region is required for ICP27 function, we deleted the sequences in the ICP27 gene which encode it (codons 12 through 63). In transient expression assays, the deletion mutant was unable to efficiently repress the expression of a cotransfected reporter gene or to efficiently complement the growth of d27-1, an HSV-1 ICP27 null mutant.
The lytic infection of a susceptible cell by herpes simplex virus type 1 (HSV-1) consists of a temporally regulated program of viral gene expression, viral DNA replication, and virion assembly (reviewed in reference 36). The HSV-1 genome, a linear molecule of double-stranded DNA, is approximately 152,000 bp in size and encodes over 70 proteins. Soon after the virus penetrates the cell, the viral genome enters the nucleus, where the viral genes are transcribed by the host RNA polymerase II. The first genes to be transcribed are called ot (or immediate-early) genes. As discussed in more detail below, the ot genes encode proteins which regulate the infectious process. One function of the a proteins is to induce the transcription of the (or delayedearly) genes. The protein products of the genes are largely enzymes involved in viral DNA synthesis. Soon after the expression of proteins, viral DNA replication begins. The process of viral DNA replication is critical for the expression of the last set of viral genes, the ry (or late) genes. The y genes for the most part encode proteins which are components of the virus particle or are involved in its assembly. The ry genes have been subdivided according to the extent to which their expression requires viral DNA replication; the expression of y-1 (or leaky-late) genes is reduced but readily detectable in the absence of DNA replication, while the expression of -y-2 (or true-late) genes is more stringently dependent on DNA replication. Following -y gene expression, DNA-containing virions are assembled in the cell nucleus and then mature and exit the cell via a complex interaction with the host secretory apparatus.
Genetic studies have demonstrated that two of the five ao proteins have regulatory roles which are essential for viral growth (7, 25, 29, 37) . One of these, infected cell protein 4 (ICP4), is the major transcription-activating protein of HSV-1; it is required throughout infection for the transcription of the L and y genes (14, 29, 47) . The 175-kDa ICP4 polypeptide has an intrinsic sequence-specific DNA-binding activity (19) , but it is not yet clear how this activity is involved in transcriptional activation (40, 41) . The second essential a protein is the 63-kDa ICP27 polypeptide. As discussed below, ICP27 appears to mediate the transition between the and y phases of viral infection. Like ICP4, ICP27 is a phosphoprotein which accumulates in the cell nucleus (1, 20, 49) , but its biochemical properties have not been characterized in great detail. Recently, it was reported that purified ICP27 can bind to zinc ions and can interact with single-stranded DNA (46) .
The analysis of viral mutants containing temperaturesensitive mutations in the ICP27 gene first demonstrated that ICP27 has an essential regulatory role during infection (37) . Subsequently, viral deletion mutants which do not express ICP27 or any fragment of it were isolated (25, 33) . Such mutants are defective for growth in normal cells but can be efficiently propagated in ICP27-expressing cell lines. These mutants exhibit a 5-to 10-fold reduction in viral DNA replication, fail to repress gene expression at late times, and show dramatically reduced levels of y-1 and y-2 gene expression. Several other ICP27 virus mutants, including five nonsense mutants and one in-frame deletion mutant, have been isolated (26, 33) . One nonsense mutant, n504R, has a phenotype which is of particular interest (33 (17, 26, 35 (32) . The CAT activities were normalized according to the protein content of each extract. Western blotting was carried out as described previously (35) , using a 1:300 dilution of H1113, a monoclonal antibody directed against ICP27 (1). The virus complementation assays were carried out as described previously (35) except that at 2 h postinfection (hpi), the cells were treated for 2 min with a glycine-saline solution (pH 3.0) as described by Cai et al. (4) . This treatment significantly lowered the level of background unadsorbed virus without significantly affecting virus yields (34) .
Isolation of mutant viruses. The isolation of ICP27 mutant viruses was carried out by a marker transfer protocol that we have previously described (33) . Briefly, plasmids pPsdl-2a and pPsdl-2b were cleaved with PstI and individually cotransfected into V27 cells with infectious d27-lacZ1 DNA. The progeny from the cotransfection were plated in V27 cells in the presence of 5-bromo-4-chloro-3-indolyl-3-D-galactopyranoside. Potential viral recombinants were isolated as clear plaques against the background of parental blue plaques. To test whether the isolates encoded a deleted form of ICP27, individual clear plaques were used to infect 25-cm2 flasks of V27 cells. The cultures were harvested when all the cells showed cytopathic effects. The resulting virus stocks were diluted 1:10 and used to inoculate cultures of Vero cells. Proteins were harvested at 8.5 hpi and subjected to Western blot analysis using the H1113 antibody. Several of the plaques gave rise to stocks which produced an immunoreactive protein of the expected size (approximately 52 kDa). Two such plaques, arising from marker transfers carried out with pPsdl-2a and pPsdl-2b DNAs, respectively, were plaque purified in V27 cells and designated dl-2a and dl-2b. Southern blot analysis of the viral DNAs confirmed that the dl-2a and dl-2b alleles had been successfully introduced into the recombinant viral genomes in place of the WT ICP27 gene (34) .
Analysis of mutant viruses.
To analyze viral DNA replication, 25-cm2 culture flasks of Vero or V27 cells were mock infected or were infected with WT HSV-1 or various ICP27 mutants. At 9 hpi, the medium was replaced with 2 ml of medium containing 25 ,uCi of [3H]thymidine (New England Nuclear) per ml. At 12 hpi, the labeling medium was replaced with 3 ml of lysis buffer containing 10 mM Tris hydrochloride (pH 8), 10 mM EDTA, 2% sodium dodecyl sulfate (SDS), and 100 ,ug of proteinase K per ml. After overnight incubation at 37°C, sodium acetate was added to 0.3 M, and the lysates were extracted once with phenolchloroform-isoamyl alcohol (24:24:1) and once with chloroform-isoamyl alcohol (24:1). Nucleic acids were precipitated after the addition of 2 volumes of ethanol and resuspended in 0.5 ml of 10 mM Tris hydrochloride (pH 8.0)-i mM EDTA (TE buffer). The samples were digested with 25 ,ug of RNase A per ml for 30 min at 37°C, phenol-chloroform-isoamyl alcohol extracted as described above, and made 0.8 M in sodium chloride. An equal volume of 13% polyethylene glycol (average molecular weight, 8,000) was added. The samples were incubated on ice for 1 h and then centrifuged for 10 min at 13,000 x g. The DNA pellets were washed with 70% ethanol, dried, and resuspended in TE buffer. DNA concentration were determined by measuring UV absorbance at 260 nm. Equal amounts of each DNA preparation (4 ,ug) were digested with EcoRI and XbaI and electrophoresed on a 0.9% agarose gel. After electrophoresis, the gel was treating with a fluorography-enhancing agent (Entensify; DuPont Corp.), dried, and exposed to X-ray film at -70°C.
For analysis of protein synthesis, infected cells were pulse-labeled for 30 min with 15 ,uCi of [35S]methioninecysteine (Tran35S-label; ICN Biomedicals) per ml. Harvesting of infected-cell proteins and SDS-polyacrylamide gel electrophoresis (PAGE) in 9.25% polyacrylamide gels were performed as described previously (13, 21) .
Cytoplasmic RNA for Northern (RNA) blot analysis was prepared at 12 hpi by extraction of the infected cells with 0.5% Nonidet P-40 (24), followed by phenol-chloroform extaction of the supernatant and ethanol precipitation. The RNA was then resuspended in TE buffer, digested with RNase-free DNase (Boehringer Mannheim), phenol-chloroform extracted, and ethanol precipitated. Ten micrograms of each RNA sample was subjected to electrophoresis through denaturing formaldehyde-agarose gels and transferred to GeneScreen filters (DuPont). Hybridization of 32P-labeled DNA probes, radiolabeled by the random primer extension method (2), was carried out overnight at 68°C in 6 x SSC (1 x SSC is 0.15 M sodium chloride plus 0.015 M sodium citrate)-5x Denhardt solution (lx Denhardt solution is 0.2% [wt/vol] bovine serum albumin, Ficoll [molecular weight, 400,000], and polyvinyl pyrrolidone)-0.5% SDS-250 ,ug of denatured salmon sperm DNA per ml. The filters were washed twice at 650C in 2x SSC-0.1% SDS and then three times at 650C in 0.2x SSC-0.1% SDS. The dried filters were then exposed to X-ray film. Plasmid DNAs were used for the hybridization probes. For the ICP8 (UL29) gene probe, plasmid pE/3583 (12) was used. Plasmid pBICP5 served as the ICP5 (UL19) gene probe. This plasmid was generated by cloning the BamHI insert from the bacteriophage M13 clone, ICP5a (14) , into the BamHI site of pUC19. Plasmid pEcoRIBamHI-I-I (11) was used as the glycoprotein C (UL44) gene probe.
RESULTS
Analysis of plasmids encoding an ICP27 molecule lacking an acidic N-terminal region. To test the functional role of the acidic N-terminal region of ICP27, we used site-specific mutagenesis to alter an ICP27-encoding plasmid so that the sequences encoding this region were deleted. The parental plasmid was pBS27, which contains a 2. (32, 37). The mutant derivative, pBSdl-2, contained a deletion in the N-terminal coding region of the ICP27 gene which resulted in the removal of codons 12 through 63 (Fig. 1) . Twenty of the 52 codons deleted encode negatively charged aspartic and glutamic residues, while 9 encode serine residues which are potential sites of phosphorylation. Two independently derived isolates of the mutant plasmid were recovered and designated pBSdl-2a and pBSdl-2b. These were analyzed separately in the experiments described below.
We first investigated whether the mutant ICP27 plasmids had alterations in the ability to transactivate gene expression in transfected cells. The reporter gene used was gBCAT (-175), a construct in which the HSV-1 glycoprotein B gene promoter drives expression of the CAT gene (32) . We have previously shown that this gene is induced by ICP27, either alone or in concert with other herpesvirus transactivators (32) . WT or mutant ICP27 plasmids were cotransfected into Vero cells with pgBCAT(-175), and 2 days later the cells were harvested and tested for CAT activity. As a negative control, we also transfected the mutant ICP27 plasmid pBH-59R (35) , which encodes a truncated ICP27 molecule of 59 amino acid residues. This mutant has previously been shown to be defective for both the transactivation and transrepression functions of ICP27 (35) . The results of the CAT assay are shown in Fig. 2A . As expected, the WT ICP27 plasmid showed a significant (seven-to eightfold) induction of CAT activity, whereas plasmid pBH59R was not able to transactivate expression of the reporter gene. Both isolates of plasmid pBSdl-2 showed transactivation levels that were comparable to that of the WT To determine whether the acidic region of ICP27 is involved in an activity necessary for lytic viral replication, we examined whether the mutant plasmids could complement the growth of a viral mutant, d27-1 (33), which does not express ICP27 because of a large deletion (Fig. 1) . Vero cells were transfected with pUC19, pBS27, pBSdl-2a, or pBSdl-2b DNA. The following day, the cells were infected with d27-1 and allowed to undergo one infectious cycle. Virus yield was determined by plaque assay on a cell line, V27 (33), which is permissive for d27-1 growth as the result of the expression of a stably transfected ICP27 gene. No viral growth was detected in the culture transfected with pUC19, whereas transfection with pBS27 increased the yield of d27-1 by more than 4 orders of magnitude (Table 1) . Transfection with the pBSdl-2 plasmids resulted in virus yields that were 2 to 8% of the WT value. These results suggest that the N-terminal acidic region of ICP27 is required for a function needed for the efficient replication of the virus in Vero cells.
However, it is possible that deletion of the acidic region of ICP27 causes the mutant polypeptide to be less stable than the WT protein. If so, we could not conclude that the deletion directly affected a regulatory activity of ICP27. To test the stability of the mutant polypeptides, we transfected Vero cells with the WT or mutant plasmids. The expressed proteins were analyzed by SDS-PAGE and Western blot analysis, using a monoclonal antibody specific for ICP27 (Fig. 3A) . The pBSdl-2 plasmids encoded smaller ICP27-related proteins with apparent molecular sizes of 52 kDa, consistent with the predicted size. Furthermore, the mutant proteins accumulated to levels that were comparable to that of the WT protein expressed from the pBS27 plasmid. We also used immunofluorescence microscopy to examine the cellular localization of the mutant proteins in transfected cells. Like the WT protein, the mutant proteins were almost exclusively nuclear (34) . Therefore, the defects in transrepression and virus complementation exhibited by the dl-2 plasmid mutants appear to result directly from an altered regulatory function of ICP27.
The acidic amino-terminal region of ICP27 is required for lytic viral growth. To study the function of the acidic N-terminal portion of ICP27 in the viral infection, we used a marker transfer protocol (33) out in ICP27-expressing V27 cells, so that potential deficiencies in viral growth would be complemented by the expression of WT ICP27. Two independent isolates of the desired mutant were obtained and designated dl-2a and dl-2b. These mutants were generated using the dl-2a and dl-2b plasmid DNAs, respectively, as gene donors. Southern blotting experiments confirmed that both viral isolates contained the dl-2 mutant alleles at the ICP27 locus (34) .
The dl-2 stocks generally failed to form plaques when titrated on Vero cells, indicating that the deletion had inactivated an essential function of ICP27. However, in some experiments the mutant stocks formed very minute plaques on Vero cells. Therefore, to study the effect of the dl-2 mutation on viral growth in more detail, single-cycle virus growth experiments were performed at a multiplicity of infection of 10 ( Table 2 ). The dl-2a and dl-2b stocks were both defective for growth in Vero cells in this assay, replicating approximately 100-fold less efficiently than the parental WT strain, KOS1.1. Additional experiments showed that the dl-2 mutants gave a similar low yield if the infections (Fig. 1 ), which were reduced in yield in Vero cells by more than 6 and 3 log units, respectively, compared with the WT virus.
To test the possibility that dl-2 polypeptide was unstable in infected cells, we analyzed the steady-state level of ICP27 proteins produced in the WT and dl-2a mutant infections. Total proteins from infected cells were isolated at 4, 9, and 14 hpi and subjected to Western blot analysis (Fig. 3B) . The mutant ICP27 protein synthesized in dl-2a-infected cells had an apparent molecular size of 51 kDa, similar to the size observed in transfected cells. At all time points tested, the mutant protein accumulated to levels that were equal or greater than the WT protein level. Similar results were observed for the mutant polypeptide expressed by the d1-2b virus (34) . Furthermore, immunofluorescence experiments indicated that the mutant ICP27 proteins expressed in dl-2a-and dl-2b-infected Vero cells accumulated predominately in the cell nucleus (34) . Therefore, the growth defect of the dl-2 mutants in Vero cells does not appear to be due to either instability of the mutant protein or a defect in its nuclear localization.
The dl-2 mutants are deficient in viral DNA replication. The dl-2 isolates are the first ICP27 virus mutants to be isolated which encode proteins with alterations specifically in the N-terminal half of ICP27. It was therefore of interest to characterize their phenotypes in detail. First, we studied the ability of the dl-2 isolates to replicate viral DNA. Vero cells were mock infected or were infected with either WT HSV-1, dl-2a, or dl-2b, the ICP27 null mutant d27-1, or the ICP27 C-terminal mutant n5O4R. As a control, the same inocula were used to infect parallel cultures of V27 cells. The cultures were labeled with [3H]thymidine from 9 to 12 hpi.
After labeling, the total DNA from the cultures was isolated and equal amounts were analyzed by restriction enzyme digestion (EcoRI plus XbaI), gel electrophoresis, and fluorography. The results from the Vero cell infections indicated the ICP27 mutants differed significantly in their abilities to replicate viral DNA (Fig. 4A) . Both isolates of the dl-2 mutant showed defects in viral DNA synthesis. Consistent with our previous results (33), the ICP27 null mutant d27-1 also exhibited a deficiency in viral DNA replication. Densitometric analysis of autoradiograms indicated that the dl-2a and dl-2b mutants replicated 3-and 8-fold less DNA, respectively, during the labeling period than did the WT virus, while the d27-1 mutant replicated 12-fold less DNA. The n5O4R mutant, on the other hand, replicated viral DNA as well as did the WT virus. This result is consistent with our previous phenotypic analysis of this mutant (33) . All of the viruses replicated viral DNA to similar extents in V27 cells (Fig. 4B) [3H]thymidine from 9 to 12 hpi. Total DNA was then purified, and equal amounts were digested with EcoRI plus XbaI and electrophoresed on a 0.9% agarose gel. The gel was processed for fluorography, dried, and exposed to X-ray film. The n504R genome contains an XbaI site at the 3' end of the ICP27 gene ( Fig. 1) and therefore gives rise to a novel EcoRI-XbaI restriction fragment.
with ICP27 mutants. At 4, 9, or 14 hpi, the cultures were pulse-labeled with [35S]methionine-cysteine, and the proteins were analyzed by SDS-PAGE and autoradiography (Fig. 5) with the WT infection. This result was consistent with the protein synthesis analysis, which showed that ,B protein repression was somewhat delayed in the dl-2 infections (Fig.  5, 9 hpi). The d27-1 and n5O4R infections, however, showed a more dramatic overexpression of ICP8 mRNA at 12 hpi, consistent with the high levels of protein synthesis that were observed at late times. The expression of a -y-1 mRNA, that encoding the major capsid protein ICP5, was next examined (Fig. 6B) . Expression of ICP5 mRNA was reduced in the dl-2 infections compared with the WT infection. A similar reduction was seen in the d27-1 infection. The n5O4R infection, on the other hand, showed WT levels of ICP5 mRNA. The levels of ICP5 mRNA in the various infections correlated qualitatively with the levels of ICP5 protein synthesis that were observed at late times (Fig. 5, 14 h ). Finally, we examined the expression of a well-characterized -y-2 mRNA, that encoding the glycoprotein C (gC; Fig. 6C ). Accumulation of gC mRNA was only modestly reduced in the d1-2a and dl-2b infections compared with the WT infection, showing three-and twofold reduction, respectively, as determined by densitometric analysis. In contrast, accumulation of gC mRNA was quite deficient in the d27-1 and n5O4R infections. In the case of the d27-1 infection, gC mRNA was undetectable, while the levels in the n5O4R infection were reduced 13-fold compared with the WT infection.
The results presented above demonstrate that the two dl-2 isolates exhibit similar defects in viral gene expression. Specifically, the dl-2 mutants show both a reduction in the expression of -y mRNAs and proteins and a delay in the down-regulation of 1 mRNAs and proteins. These modest deficiencies are in contrast to the more striking defects in gene expression which are exhibited by the ICP27 null mutant d27-1 and the ICP27 C-terminal mutant n5O4R. in two respects. First, the synthesis of several -y proteins was somewhat deficient at the later time points. This was most easily seen for the high-molecular-weight ICP1-2 polypeptide. The synthesis of several other y proteins, such as ICP5, was also reduced but to a lesser extent than that of ICP1-2. Second, the repression of synthesis of several ,B proteins, including ICP6 and ICP8, was delayed in the dl-2 infections compared with the WT infection.
The pattern of viral protein synthesis exhibited by the dl-2 mutants was quite different from the patterns shown by the d27-1 and n504R mutants, both of which showed patterns that were consistent with our previous analysis (33) . First, the dl-2 mutants, like the WT virus, were able to efficiently repress the expression of the a protein ICP4 at late times after infection. In contrast, neither the d27-1 nor the n504R mutant was able to efficiently down-regulate ICP4 expression. Second, the dl-2 mutants appeared to have a much less severe defect in the repression of protein synthesis than did the d27-1 and n504R mutants. Third, the dl-2 mutants were able to induce the synthesis of certain -y proteins such as ICP15, which were not induced to appreciable extents in the d27-1 and n504R infections.
To study dl-2a and dl-2b gene expression in more detail, we examined the accumulation of specific mRNAs from well-characterized 1, -y-1, and -y-2 genes. Vero cells were mock infected or were infected with the WT virus or ICP27 mutants. Cytoplasmic RNA was isolated at 12 hpi and analyzed by Northern blot analysis. We first studied the expression of a mRNA, that encoding the major DNAbinding protein, ICP8 (Fig. 6A) . The dl-2 infections both showed a modest overexpression of ICP8 mRNA compared DISCUSSION A striking feature of the primary sequence of ICP27 is the high proportion of acidic amino acid residues in its N-terminal region. Nearly 40% of the 64 N-terminal residues of ICP27 consist of aspartic or glutamic acid. The presence of an acidic region in this viral gene-regulatory protein is of interest for two reasons. First, acidic regions are found in many viral and cellular transcription factors and have been implicated in transcriptional activation. They are thought to function via an interaction with one or more components of the RNA polymerase II transcription complex (43) . Second, several other herpesviruses have been shown to possess open reading frames (ORFs) with some degree of amino acid homology to ICP27. These ORFs include varicella-zoster virus ORF 4 (6), equine herpesvirus 1 ORF 5 (45, 51), Epstein-Barr virus BMLF1 (6) , and the herpesvirus saimiri 52-kDa ORF (28) . Although the homology between ICP27 and these ORFs is mostly limited to their C-terminal halves, all contain a cluster of acidic residues at their N termini. This observation raises the possibility that the acidic region of ICP27 is involved in a function common to diverse herpesviruses.
The acidic N-terminal region of ICP27 is required for efficient transrepression in transfected cells. To study the function of the acidic region of ICP27, we constructed an ICP27 gene in which the sequences encoding it (codons 12 through 63) were deleted. The mutant gene was tested in a number of transfection assays designed to measure the properties and functions of ICP27 in uninfected cells. These experiments indicated that the N-terminal deletion did not affect the stability or nuclear localization of ICP27 or its J. VIROL. ability to transactivate the expression of a reporter gene. However, the deletion did significantly reduce the ability of ICP27 to transrepress gene expression in transfected cells. This result is noteworthy because previous studies have concluded that the transrepressing activity of ICP27 maps to its C-terminal half (17, 26) . Although it is clear that regions in the C-terminal half of the molecule are required for transrepression, the only published data which might argue against an important contribution of the N-terminal half are the experiments of Hardwicke et al. (17) . These investigators constructed plasmids having in-frame oligonucleotide insertions at many sites in the ICP27 coding region. It was found that insertions in the N-terminal half of the ICP27 gene, including insertions between residues 28 and 29 and residues 58 and 59, had no effect on transrepression. The combined results thus suggest that the specific amino acid sequence of the N-terminal region of ICP27 may not be as important as a general biochemical feature of this region, such as its high negative charge. If so, the N-terminal region of ICP27 may be similar to the negatively charged domains of transcription factors, many of which do not appear to depend on specific amino acid sequences (23) . It will be of interest to determine whether other acidic sequences can substitute for the acidic region of ICP27.
The acidic N-terminal region of ICP27 is required for an essential lytic function. Our plasmid complementation assay suggested that the acidic region of ICP27 is required for efficient viral growth. To test this possibility directly, we introduced the mutant ICP27 allele into the HSV-1 genome in place of the WT gene. Two independently derived isolates of the recombinant virus, dl-2a and dl-2b, were recovered and separately characterized. This was done to exclude the possibility that an unintended, secondary mutation might contribute to the observed phenotype of the dl-2 mutant. However, the two isolates exhibited very similar, if not identical, phenotypic properties. In addition, the growth defects of both mutants could be complemented by the WT tCP27 expressed from V27 cells. These results together show that the phenotype displayed by the dl-2 isolates resulted directly from the engineered mutation.
Single-cycle growth experiments indicated that the virus yield from dl-2-infected Vero cells was reduced approximately 100-fold compared with the WT infection. Therefore, we conclude that the acidic N-terminal region of ICP27 is required for an essential lytic function. To gain insight into that function, we examined viral DNA replication and gene expression in dl-2-infected cells. We found that the mutant infections differed from the WT infection in two respects. First, the dl-2 isolates were deficient in viral DNA replication, showing a three-to eightfold reduction in the level of DNA synthesis. Second, the dl-2 mutants exhibited modest deficiencies in viral gene expression. Specifically, dl-2-infected cells showed both a reduction in the level of y gene expression and a delay in the repression of ,B gene expression.
Inhibition of HSV-1 DNA synthesis by a variety of means results in both a reduction in -y gene expression and a potentiation of 1 gene expression (36) . Therefore, the simplest hypothesis that would explain the phenotype of dl-2 is that the primary effect of the mutation is to reduce the amount of viral DNA replication. The reduced amounts of DNA replication in dl-2-infected cells might result indirectly in the observed alterations in viral gene expression. However, at present we cannot exclude the possibility that the dl-2 mutation has a direct effect on gene expression in infected cells. Indeed, our finding that the dl-2 plasmid mutant is defective for transrepression in transfected cells is consistent with this latter possibility.
Stimulation of viral DNA replication by ICP27. Our results demonstrate that ICP27 has a specific role in stimulating viral DNA replication in infected cells. However, ICP27 is not one of the seven HSV-1 replication proteins which are thought to participate directly in the DNA replication process (reviewed in reference 48). Indeed, these seven viral proteins are sufficient in transfected cells to direct replication from an HSV-1 origin of replication contained on a plasmid molecule (ori-plasmid) (50) . How then does ICP27 stimulate the level of viral DNA replication in infected cells? One possibility is that ICP27 stimulates the expression of one or more of the replication proteins, which are of the ,B kinetic class. This explanation appears unlikely, however, because the major 13 genes that we examined, ICP6 and ICP8, were not underexpressed in either dl-2 or d27-1 infections. In fact, these genes were overexpressed at late times. This latter observation raises a second possibility, which is that the overexpression of 13 proteins inhibits viral DNA replication to some extent. However, this explanation also appears unlikely because the n504R mutant shows elevated levels of 13 gene expression but is not defective for DNA replication. A third possibility, and the one that we favor, is that ICP27 stimulates DNA replication not by an effect on viral gene expression but in a more direct capacity, perhaps by altering the posttranslational modification of host or viral proteins (26, 32, 44) . Further experiments will be required to distinguish between these and other possibilities.
It is of interest that ICP27 was identified as a stimulatory factor in the original ori-plasmid replication assays used to map the HSV-1 replication genes (50) . At the time, it was suggested that ICP27 stimulated plasmid replication by transactivating one or more of the seven HSV-1 replication genes. However, we have shown that the dl-2 allele is not defective for transactivation in a transfection assay but does lead to a viral DNA replication defect when introduced into a recombinant virus. This finding suggests that ICP27 may stimulate DNA replication in the ori-plasmid replication assays by a mechanism other than transactivation. It will be of interest to determine whether the dl-2 protein can stimulate the replication of an ori-plasmid in transfected cells.
ICP27 mediates multiple activities in infected cells. We previously suggested that ICP27 carries out two distinct regulatory functions during the HSV-1 infection (33) . This hypothesis was based on the phenotypic analysis of several viral ICP27 mutants, including the null mutant d27-1 and the C-terminal mutant n504R. The d27-1 mutant showed defects in viral DNA replication, -y-1 gene expression, and -y-2 gene expression, whereas the n504R mutant exhibited only defects in -y-2 gene expression. Therefore, we proposed that ICP27 mediates two genetically separable activities in infected cells: (i) an activity that stimulates viral DNA replication and fy-1 gene expression and (ii) an activity that transactivates -y-2 genes, independent of viral DNA replication. The phenotype of the dl-2 mutant can be considered in the context of this model if we hypothesize that it is defective in the first but not the second activity. This mutant exhibits a deficiency in -y-1 gene expression and viral DNA replication and shows a modest reduction in y-2 gene expression. However, the reduction in y-2 gene expression in dl-2-infected cells is consistent with the three-to eightfold defect in viral DNA replication that is observed and contrasts quite dramatically with the more severe reductions in -y-2 gene expression which are observed in d27-1-infected VOL. 67, 1993 cells (in which DNA replication is defective) and n5O4R-infected cells (in which DNA replication is normal).
However, some of our results are not entirely consistent with these interpretation. For example, d27-1-infected cells show a striking defect in the induction of ICP5 and at least two other proteins at early times (Fig. 5, 4 hpi). This effect is not observed in cells infected by dl-2 or n504R. Therefore, d27-1-and dl-2-infected cells induce the -y-1 protein ICP5 and some other proteins with quite different kinetics, even though they appear to be similarly defective for viral DNA replication. Thus, ICP27 may induce -y-l genes by multiple mechanisms. In addition, if the defective functions of dl-2 and n504R are completely independent, then two mutants should be capable of intragenic complementation. We have failed to observe such complementation (34) , suggesting that they are not completely independent.
The current evidence suggests that ICP27 is a multifunctional protein. It appears to regulate viral gene expression at both the transcriptional (18, 25) and posttranscriptional (38, 42) levels and is required for efficient viral DNA replication (25, 33; 
